Omnicell Inc. Stock
Price
Target price
€35.40
€35.40
-1.670%
-0.6
-1.670%
€44.97
03.06.26 / Frankfurt
WKN: 632313 / Symbol: OMCL / Name: Omnicell / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omnicell Inc. Stock
A loss of -1.670% shows a downward development for Omnicell Inc..
Omnicell Inc. is currently one of the favorites of our community with 11 Buy predictions and no Sell predictions.
As a result the target price of 44 € shows a positive potential of 24.29% compared to the current price of 35.4 € for Omnicell Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Omnicell Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -1.670% | -3.804% | 0.568% | 31.111% | -8.763% | -48.321% | -68.393% |
| Healthequity Inc. | 0.000% | 1.351% | 7.914% | -15.254% | -3.846% | 45.631% | 11.607% |
| Bruker Corp. | 5.540% | 29.229% | 72.794% | 64.336% | 32.508% | -19.328% | - |
| Myriad Genetics | 0.110% | 10.377% | -8.161% | -3.880% | -30.358% | -83.069% | -83.574% |
Comments
Omnicell (OMCL) had its "buy" rating reaffirmed by Craig Hallum.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (OMCL) had its "overweight" rating reaffirmed by KeyCorp.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (OMCL) had its price target raised by Wells Fargo & Company from $52.00 to $55.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
News
Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing
On April 29, 2026, Avory & Company, LLC disclosed in a U.S. Securities and Exchange Commission (SEC) filing that it sold 156,571 shares of Omnicell (NASDAQ:OMCL), an estimated $6.55 million
Why Omnicell Stock Trounced the Market on Tuesday
Omnicell (NASDAQ: OMCL) is off to a roaring start this year, at least as far as its quarterly performance is concerned. On Tuesday, it published its first earnings report of the year, and Mr. Market
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell (NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.